Literature DB >> 20826656

Induced loss of ADAR2 engenders slow death of motor neurons from Q/R site-unedited GluR2.

Takuto Hideyama1, Takenari Yamashita, Takeshi Suzuki, Shoji Tsuji, Miyoko Higuchi, Peter H Seeburg, Ryosuke Takahashi, Hidemi Misawa, Shin Kwak.   

Abstract

GluR2 is a subunit of the AMPA receptor, and the adenosine for the Q/R site of its pre-mRNA is converted to inosine (A-to-I conversion) by the enzyme called adenosine deaminase acting on RNA 2 (ADAR2). Failure of A-to-I conversion at this site affects multiple AMPA receptor properties, including the Ca(2+) permeability of the receptor-coupled ion channel, thereby inducing fatal epilepsy in mice (Brusa et al., 1995; Feldmeyer et al., 1999). In addition, inefficient GluR2 Q/R site editing is a disease-specific molecular dysfunction found in the motor neurons of sporadic amyotrophic lateral sclerosis (ALS) patients (Kawahara et al., 2004). Here, we generated genetically modified mice (designated as AR2) in which the ADAR2 gene was conditionally targeted in motor neurons using the Cre/loxP system. These AR2 mice showed a decline in motor function commensurate with the slow death of ADAR2-deficient motor neurons in the spinal cord and cranial motor nerve nuclei. Notably, neurons in nuclei of oculomotor nerves, which often escape degeneration in ALS, were not decreased in number despite a significant decrease in GluR2 Q/R site editing. All cellular and phenotypic changes in AR2 mice were prevented when the mice carried endogenous GluR2 alleles engineered to express edited GluR2 without ADAR2 activity (Higuchi et al., 2000). Thus, loss of ADAR2 activity causes AMPA receptor-mediated death of motor neurons.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20826656      PMCID: PMC6633551          DOI: 10.1523/JNEUROSCI.2021-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  63 in total

Review 1.  Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis.

Authors:  Lee J Martin; Qing Chang
Journal:  Mol Neurobiol       Date:  2011-11-10       Impact factor: 5.590

Review 2.  Activity regulation of adenosine deaminases acting on RNA (ADARs).

Authors:  Cesare Orlandi; Alessandro Barbon; Sergio Barlati
Journal:  Mol Neurobiol       Date:  2011-11-20       Impact factor: 5.590

3.  Activity-dependent A-to-I RNA editing in rat cortical neurons.

Authors:  Neville E Sanjana; Erez Y Levanon; Emily A Hueske; Jessica M Ambrose; Jin Billy Li
Journal:  Genetics       Date:  2012-06-19       Impact factor: 4.562

4.  Exposure of neurons to excitotoxic levels of glutamate induces cleavage of the RNA editing enzyme, adenosine deaminase acting on RNA 2, and loss of GLUR2 editing.

Authors:  S S Mahajan; K H Thai; K Chen; E Ziff
Journal:  Neuroscience       Date:  2011-05-19       Impact factor: 3.590

Review 5.  The emerging role of RNA editing in plasticity.

Authors:  Joshua J C Rosenthal
Journal:  J Exp Biol       Date:  2015-06       Impact factor: 3.312

Review 6.  Novel RNA modifications in the nervous system: form and function.

Authors:  John S Satterlee; Maria Basanta-Sanchez; Sandra Blanco; Jin Billy Li; Kate Meyer; Jonathan Pollock; Ghazaleh Sadri-Vakili; Agnieszka Rybak-Wolf
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

7.  ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD.

Authors:  Stephen Moore; Eric Alsop; Ileana Lorenzini; Alexander Starr; Benjamin E Rabichow; Emily Mendez; Jennifer L Levy; Camelia Burciu; Rebecca Reiman; Jeannie Chew; Veronique V Belzil; Dennis W Dickson; Janice Robertson; Kim A Staats; Justin K Ichida; Leonard Petrucelli; Kendall Van Keuren-Jensen; Rita Sattler
Journal:  Acta Neuropathol       Date:  2019-04-03       Impact factor: 17.088

Review 8.  Modeling simple repeat expansion diseases with iPSC technology.

Authors:  Edyta Jaworska; Emilia Kozlowska; Pawel M Switonski; Wlodzimierz J Krzyzosiak
Journal:  Cell Mol Life Sci       Date:  2016-06-03       Impact factor: 9.261

Review 9.  RNA-binding proteins in neurodegeneration: Seq and you shall receive.

Authors:  Julia K Nussbacher; Ranjan Batra; Clotilde Lagier-Tourenne; Gene W Yeo
Journal:  Trends Neurosci       Date:  2015-03-09       Impact factor: 13.837

10.  A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology.

Authors:  Takenari Yamashita; Takuto Hideyama; Kosuke Hachiga; Sayaka Teramoto; Jiro Takano; Nobuhisa Iwata; Takaomi C Saido; Shin Kwak
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.